| Year |
Citation |
Score |
| 2023 |
Roberts NS, Handy MJ, Ito Y, Hashimoto K, Jensen FE, Talos DM. Anti-seizure efficacy of perampanel in two established rodent models of early-life epilepsy. Epilepsy & Behavior : E&B. 143: 109194. PMID 37119576 DOI: 10.1016/j.yebeh.2023.109194 |
0.446 |
|
| 2021 |
Gourmaud S, Stewart DA, Irwin DJ, Roberts N, Barbour AJ, Eberwine G, O'Brien WT, Vassar R, Talos DM, Jensen FE. The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease. Brain : a Journal of Neurology. PMID 34264340 DOI: 10.1093/brain/awab268 |
0.376 |
|
| 2020 |
Jones JE, Asato MR, Brown MG, Doss JL, Felton EA, Kearney JA, Talos D, Dacks PA, Whittemore V, Poduri A. Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span. Epilepsy Currents. 1535759719895277. PMID 31973592 DOI: 10.1177/1535759719895277 |
0.416 |
|
| 2019 |
Gourmaud S, Shou H, Irwin DJ, Sansalone K, Jacobs LM, Lucas TH, Marsh ED, Davis KA, Jensen FE, Talos DM. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain : a Journal of Neurology. PMID 31834353 DOI: 10.1093/Brain/Awz381 |
0.315 |
|
| 2018 |
Talos DM, Jacobs LM, Gourmaud S, Coto CA, Sun H, Lim KC, Lucas TH, Davis KA, Martinez-Lage M, Jensen FE. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy. Annals of Neurology. PMID 29331082 DOI: 10.1002/Ana.25149 |
0.415 |
|
| 2016 |
Butler T, Li Y, Tsui W, Friedman D, Maoz A, Wang X, Harvey P, Tanzi E, Morim S, Kang Y, Mosconi L, Talos D, Kuzniecky R, Vallhabjosula S, Thesen T, et al. Transient and chronic seizure-induced inflammation in human focal epilepsy. Epilepsia. PMID 27381590 DOI: 10.1111/Epi.13457 |
0.322 |
|
| 2013 |
Cleary RT, Sun H, Huynh T, Manning SM, Li Y, Rotenberg A, Talos DM, Kahle KT, Jackson M, Rakhade SN, Berry G, Berry G, Jensen FE. Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. Plos One. 8: e57148. PMID 23536761 DOI: 10.1371/Journal.Pone.0057148 |
0.455 |
|
| 2013 |
Talos DM, Chang M, Kosaras B, Fitzgerald E, Murphy A, Folkerth RD, Jensen FE. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatric Research. 73: 24-30. PMID 23138400 DOI: 10.1038/Pr.2012.151 |
0.459 |
|
| 2012 |
Talos DM, Sun H, Zhou X, Fitzgerald EC, Jackson MC, Klein PM, Lan VJ, Joseph A, Jensen FE. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. Plos One. 7: e35885. PMID 22567115 DOI: 10.1371/journal.pone.0035885 |
0.447 |
|
| 2011 |
Goto J, Talos DM, Klein P, Qin W, Chekaluk YI, Anderl S, Malinowska IA, Di Nardo A, Bronson RT, Chan JA, Vinters HV, Kernie SG, Jensen FE, Sahin M, Kwiatkowski DJ. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proceedings of the National Academy of Sciences of the United States of America. 108: E1070-9. PMID 22025691 DOI: 10.1073/Pnas.1106454108 |
0.301 |
|
| 2007 |
Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5546-58. PMID 17522300 DOI: 10.1523/Jneurosci.5540-06.2007 |
0.338 |
|
| 2005 |
Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ. NKCC1 transporter facilitates seizures in the developing brain. Nature Medicine. 11: 1205-13. PMID 16227993 DOI: 10.1038/Nm1301 |
0.366 |
|
| Show low-probability matches. |